Hayasa arranges $1.7-million private placement

Executive Summary

• Hayasa Metals Inc. announced a non‑brokered private placement of up to 10 million units at C$0.17 per unit, targeting gross proceeds of up to $1.7 million.
• Proceeds will fund the 2026 Urasar drilling campaign and support exploration at Uraser and other mineral projects, with assay results from the 2025 campaign expected shortly after closing.
• The placement includes a finder's fee of up to 5 % of proceeds and may close in multiple tranches, subject to TSX‑V conditional approval.

Key Details

• Units offered: Up to 10 million units at C$0.17 per unit (≈ $1.7 M gross).
• Unit composition: Each unit = 1 common share + ½ share purchase warrant; each full warrant allows purchase of one share at C$0.22.
• Warrant period: exercisable from 61 days after closing until 18 months post‑closing.
• Exemptions used: Listed issuer financing exemption under NI 45‑106 (Part 5A) in Canada (excluding Quebec); U.S. and other jurisdictions exemptions also relied upon.
• Use of proceeds:
• Advance the 2026 Urasar drilling campaign.
• Fund assay analysis from the 2025 Urasar drill program (results expected shortly after closing).
• Support upcoming Vardenis assay releases anticipated in Q1 2026.
• Evaluate additional mineral property opportunities.
• General working capital.
• Placement leadership: Existing shareholders and insiders; directors/officers may participate under related‑party transaction exemptions (≤25 % of market cap, no formal valuation required).
• Finder’s fee: Up to 5 % of proceeds payable in cash to eligible finders.
• Closing timeline: Expected on or about September 30, 2025; may be completed in multiple tranches and is subject to TSX‑V conditional approval and other customary conditions.
• Hold period for insider units: Four‑month lock‑up per TSX‑V policy.

Notable Quotes

“This financing funds the 2026 Urasar drilling campaign, and in the meantime, investors and participants in the offering can look forward to assays from the Urasar 2025 drilling campaign expected to be released shortly after closing. Additionally, assays from Vardenis will likely be released in Q1 2026. Management is optimistic that 2026 will continue to deliver value to Hayasa shareholders.” – Joel Sutherland, CEO, Hayasa Metals Inc.